Clinical Trial Update: PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing benralizumab in children with severe eosinophilic asthma, focusing on PK/PD and long-term safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Asthma

Drugs mentioned

• Benralizumab (benralizumab)

Snippet

Sponsor: AstraZeneca | Conditions: Severe Uncontrolled Asthma | Phase 3 | Status: COMPLETED | Results posted: 2023-05-18